Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Respiratory Investigation is Scopus-indexed (Q3, CiteScore 3.1), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2212-5345Verify ISSN ↗2212-5353Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: About US$3,000 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 85 / 165 | 48th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q3, CiteScore 3.1.
Respiratory Investigation is Q3 in Pulmonary and Respiratory Medicine (rank 85 of 165), by CiteScore 2025.
Respiratory Investigation is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.1, which places it in quartile Q3 at the 48th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.573, quartile Q2, with an H-index of 48.
The publisher lists an article processing charge of about US$3,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Respiratory Investigation is published by Elsevier B.V. Its print ISSN is 2212-5345 and its online ISSN is 2212-5353.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Respiratory Investigation has an h-index of 54 and a 2-year mean of 2.23 citations per paper (OpenAlex). Its Scopus CiteScore is 3.1, quartile Q3. On 2-year citations it ranks #54 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Respiratory Investigation published 216 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2026), authors are most often from Japan (85.1%), India (5.3%) and United States (4.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.